The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes
Open accessAbstract
o-Quinones are physiological oxidation products of catecholamines that contribute to redox cycling, toxicity and apoptosis, i.e. the neurodegenerative processes underlying Parkinson's disease and schizophrenia. The present study shows that the cyclized o-quinones aminochrome, dopachrome, adrenochrome and noradrenochrome, derived from dopamine, dopa, adrenaline and noradrenaline respectively, are efficiently conjugated with glutathione in the presence of human glutathione transferase (GST) M2-2. The oxidation product of adrenaline, adrenochrome, is less active as a substrate for GST M2-2, and more efficiently conjugated by GST M1-1. Evidence for expression of GST M2-2 in substantia nigra of human brain was obtained by identification of the corresponding PCR product in a cDNA library. Glutathione conjugation of these quinones is a detoxication reaction that prevents redox cycling, thus indicating that GSTs have a cytoprotective role involving elimination of reactive chemical species originating from the oxidative metabolism of catecholamines. In particular, GST M2-2 has the capacity to provide protection relevant to the prevention of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free Radicals in Biology and Medicine
Land, E. T. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,854
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
[28] Glutathione transferase (human placenta)
Mannervik, B., & Guthenberg, C. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)77030-7 · Cited by 672
Self-citationNomenclature for human glutathione transferases
Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di Ilio, C., Ketterer, B., Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., et al. (1992) · Biochemical Journal · doi:10.1042/bj2820305 · Cited by 671
Self-citationThe scavenging of superoxide radical by manganous complexes: In vitro
Archibald, F. S., & Fridovich, I. (1982) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(82)90049-2 · Cited by 422
Dg, G. (1984) · PubMed · Cited by 292
Offen, D., Ziv, I., Sternin, H., Melamed, E., & Hochman, A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0136 · Cited by 250
Cited by
Dietary polyphenols and the prevention of diseases
Scalbert, A., Manach, C., Morand, C., Rémésy, C., & Jiménez, L. (2005) · Critical Reviews in Food Science and Nutrition · doi:10.1080/1040869059096 · Cited by 2,999
The importance of glutathione in human disease
Townsend, D. M., Tew, K. D., & Tapiero, H. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00043-x · Cited by 2,004
Hayes, J. D., & McLellan, L. I. (1999) · Free Radical Research · doi:10.1080/10715769900300851 · Cited by 1,525
Role of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
The role of glutathione-S-transferase in anti-cancer drug resistance
Townsend, D. M., & Tew, K. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206940 · Cited by 1,353
Glutathione S-Transferase Polymorphisms and Their Biological Consequences
Hayes, J. D., & Strange, R. C. (2000) · Pharmacology · doi:10.1159/000028396 · Cited by 1,001
Absorption and metabolism of polyphenols in the gut and impact on health
Scalbert, A., Morand, C., Manach, C., & Rémésy, C. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00205-6 · Cited by 717
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citationCobbina, E., & Akhlaghi, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1293683 · Cited by 653
Concise review of the glutathione S-transferases and their significance to toxicology
Eaton, D. (1999) · Toxicological Sciences · doi:10.1093/toxsci/49.2.156 · Cited by 627
Oxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Direct and indirect antioxidant properties of inducers of cytoprotective proteins
Dinkova-Kostova, A. T., & Talalay, P. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700195 · Cited by 535
Glutathione S-transferase polymorphisms: cancer incidence and therapy
McIlwain, C. C., Townsend, D. M., & Tew, K. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209373 · Cited by 523
Asanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 516
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Self-citationAntioxidant Functions of Sulforaphane: a Potent Inducer of Phase II Detoxication Enzymes
Fahey, J. W., & Talalay, P. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00082-4 · Cited by 482
Allostatic load in bipolar disorder: Implications for pathophysiology and treatment
Kapczinski, F., Vieta, E., Andreazza, A. C., Frey, B. N., Gomes, F. A., Tramontina, J., Kauer-Sant’Anna, M., Grassi-Oliveira, R., & Post, R. M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.10.005 · Cited by 480
Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
HUBATSCH, I., RIDDERSTRÖM, M., & MANNERVIK, B. (1998) · Biochemical Journal · doi:10.1042/bj3300175 · Cited by 375
Self-citationScharlau, D., Borowicki, A., Habermann, N., Hofmann, T., Klenow, S., Miene, C., Munjal, U., Stein, K., & Glei, M. (2009) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2009.04.001 · Cited by 335
Parkinson's disease, pesticides, and glutathione transferase polymorphisms
Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., & Couteur, D. G. L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03453-9 · Cited by 314
Yin, Z., Ivanov, V. N., Habelhah, H., Tew, K. D., & Ronai, Z. A. (2000) · PubMed · doi:10.7916/d8571b9j · Cited by 264
Golub, E., Albada, H. B., Liao, W.-C., Biniuri, Y., & Willner, I. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09457 · Cited by 264
Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats
Ahmad, M., Saleem, S., Ahmad, A. S., Ansari, M. A., Yousuf, S., Hoda, M. N., & Islam, F. (2005) · Human & Experimental Toxicology · doi:10.1191/0960327105ht509oa · Cited by 227
Dopamine Oxidation and Autophagy
Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J. (2012) · Parkinson's Disease · doi:10.1155/2012/920953 · Cited by 214
“4-S-Glutathionyl-5,6-dihydroxyindoline is stable in the presence of biological oxidizing agents, such as oxygen, superoxide radicals, and hydrogen peroxide [50, 51].”
BackgroundSelf-citationGawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., Yatham, L. N., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000617 · Cited by 99
“Furthermore, GST detoxifies cerebral quinones that are formed from the oxidation of dopamine and other catecholamines (Baez et al. 1997).”
Background5,6-Dihydroxyindoles and indole-5,6-diones
d’Ischia, M., Napolitano, A., Pezzella, A., Land, E. J., Ramsden, C. A., & Riley, P. A. (2005) · Advances in Heterocyclic Chemistry · doi:10.1016/s0065-2725(05)89001-4 · Cited by 86
Tabassum, R., Vaibhav, K., Shrivastava, P., Khan, A., Ejaz Ahmed, M., Javed, H., Islam, F., Ahmad, S., Saeed Siddiqui, M., Safhi, M. M., et al. (2013) · Neurological Sciences · doi:10.1007/s10072-012-1163-1 · Cited by 82
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79
sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease
Stichel, C. C., Schoenebeck, B., Foguet, M., Siebertz, B., Bader, V., Zhu, X. R., & Lübbert, H. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03859.x · Cited by 43
“…al., 1997; Ghribi et al., 2003; Wilms et al., 2003) and glutathione S-transferase mu1 (GSTM1) functions as an inhibitor of the pro-apoptotic enzyme, apoptosis signalregulating kinase 1 (ASK1) (Cho et al., 2001) and as an important cellular detoxifying enzyme (Baez et al., 1997; Owuor & Kong, 2002).”
Background
Metadata
- Authors
- BAEZ, S., SEGURA-AGUILAR, J., WIDERSTEN, M., JOHANSSON, A.-S., & MANNERVIK, B.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1997-05-15
- Volume
- 324
- Issue
- 1
- Pages
- 25-28
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1611919433
- Cited by
- 340
- References
- 21
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.